BSE - Delayed Quote INR

Vikram Thermo (India) Limited (VIKRAMTH.BO)

165.55

-3.55

(-2.10%)

At close: April 17 at 3:47:12 PM GMT+5:30

This week in Trumponomics: War on the Fed

Trump has found a new scapegoat for his tariff failures: Federal Reserve Chair Jerome Powell. Brace for more market instability.

Yahoo Finance 24 minutes ago

^IXIC

^DJI

^GSPC
Berkshire Hathaway is top defensive pick, portfolio manager says

Markets (^GSPC, ^IXIC, ^DJI) are ticking higher, but recent volatility tied to trade policy is prompting some investors to play defense. Rational Equity Fund portfolio manager Joe Tigay joins Catalysts to explain why he's turning to value plays like Berkshire Hathaway (BRK-B, BRK-A) as a top pick in uncertain times. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.

Yahoo Finance Video 6 hours ago

BRK-B

^GSPC
Netflix stock rises after earnings, outlook top Wall Street forecasts

Netflix reported first quarter earnings that beat expectations on both the top and bottom lines, with guidance for the current quarter also ahead of Wall Street estimates.

Yahoo Finance 18 hours ago

NFLX
How Eli Lilly's GLP-1 pill could transform the weight-loss space

Eli Lilly surged during Thursday's trading session after promising test results came out of the pharmaceutical company's ongoing weight-loss pill trial. Bernstein US biopharmaceuticals senior analyst Courtney Breen joins Market Domination with Host Josh Lipton, Unlimited co-founder, CEO, and chief investment officer Bob Elliott, and Yahoo Finance Senior Healthcare Reporter Anjalee Khemlani to explain why the test results sent the pharmaceutical stock soaring. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

Yahoo Finance Video 19 hours ago

LLY

NONOF

NVO
Stocks close mixed as UnitedHealth drags on the Dow

Stocks closed mixed on Thursday. The Dow Jones Industrial Average (^DJI) fell 527 points, but the decline was primarily due to the 22% drop in UnitedHealth Group (UNH) shares. Market Domination Overtime Anchor Josh Lipton and Yahoo Finance Markets & Data Editor Jared Blikre recap the action at the close. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.

Yahoo Finance Video 19 hours ago

^DJI

^IXIC

^GSPC
UnitedHealth stock is crushing the Dow. Here's the math behind the slide.

The Dow was a major laggard on Thursday due to the sharp decline in UnitedHealth shares. Here's why.

Yahoo Finance 21 hours ago

^DJI

^GSPC

DIA
Netflix Smashes Expectations with $10.54 Billion in Revenue

With subscriber counts gone, Netflix bets big on ads--and Wall Street is loving it

GuruFocus.com 5 minutes ago

NFLX
Trump Trade: President said to end IRS Direct File, block DeepSeek

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly: DEEPSEEK: After the Trump administration moved to restrict Nvidia’s (NVDA) sale of A.I. chips to China, it also is weighing penalties that would block DeepSeek, China’s artificial intelligence star, from buying U.S. technology and is debating barring Americans’ access to its services, three peopl

TipRanks 16 minutes ago

INTU

NVDA

F
H.C. Wainwright still expects Viking to ‘differentiate’ after Lilly data

H.C. Wainwright says the bar is set for oral GLP-1s following this morning’s type 2 diabetes data from Eli Lilly (LLY). The firm continues to expect Viking Therapeutics (VKTX) to “differentiate” with its dual GLP-1/GIP asset VK2735. The data collected in the Phase 1 assessing oral VK2735 is at 28 days exhibited up to an 8.2% reduction in body weight was observed, and oral VK2735 maintained excellent tolerability profile through 100 mg dose level with 99% of adverse events being mild to moderate,

TipRanks 17 minutes ago

LLY

VKTX
Eli Lilly Vows to Make Weight-Loss Pill in U.S. as Trump Pushes for Domestic Manufacturing

Eli Lilly plans to make its experimental drug orforglipron in the U.S. after it secures regulatory approval, says CEO Dave Ricks.

Barrons.com 26 minutes ago

LLY

NVO
Amkor Technology, Inc. (AMKR): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

We recently published a list of 20 Mid-Cap Stocks Insiders Were Buying in Q1 2025. In this article, we are going to take a look at where Amkor Technology, Inc. (NASDAQ:AMKR) stands against other mid-cap stocks insiders were buying in Q1 2025. Stock markets tumbled on Wednesday, with technology shares leading the slide amid growing […]

Insider Monkey 33 minutes ago

AMKR

COMP
Millrose Properties, Inc. (MRP): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

We recently published a list of 20 Mid-Cap Stocks Insiders Were Buying in Q1 2025. In this article, we are going to take a look at where Millrose Properties, Inc. (NYSE:MRP) stands against other mid-cap stocks insiders were buying in Q1 2025. Stock markets tumbled on Wednesday, with technology shares leading the slide amid growing […]

Insider Monkey 33 minutes ago

COMP

LEN-B
Eli Lilly jumps as results from weight-loss pill study rival competitor’s

Shares of Eli Lilly (LLY) jumped on Thursday morning after the company announced topline Phase 3 results from ACHIEVE-1, evaluating the safety and efficacy of orforglipron compared to placebo in adults with type 2 diabetes and inadequate glycemic control with diet and exercise alone. Commenting on the news, Leerink said that the once-daily oral GLP-1 pill showed similar efficacy and safety relative to weekly injectable semaglutide, made by Novo Nordisk (NVO). PRIMARY ENDPOINT MET: Eli Lilly anno

TipRanks 47 minutes ago

LLY

NONOF

NVO
Eli Lilly and BigHat Biosciences ink AI antibody discovery deal

The agreement adds to Eli Lilly’s growing portfolio of AI-enabled drug discovery partnerships.

Pharmaceutical Technology 55 minutes ago

LLY
Noble Corporation plc (NE): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

We recently published a list of 20 Mid-Cap Stocks Insiders Were Buying in Q1 2025. In this article, we are going to take a look at where Noble Corporation plc (NYSE:NE) stands against other mid-cap stocks insiders were buying in Q1 2025. Stock markets tumbled on Wednesday, with technology shares leading the slide amid growing […]

Insider Monkey 1 hour ago

NE-WSA

COMP
Eli Lilly and Company (LLY): One of the Best Long Term Stocks to Buy According to Billionaires

We recently published a list of the 10 Best Long Term Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best long term stocks. Dividend-paying stocks have traditionally been seen as a solid foundation for investment portfolios, offering steady […]

Insider Monkey 1 hour ago

LLY
RLI Corp. (RLI): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

We recently published a list of 20 Mid-Cap Stocks Insiders Were Buying in Q1 2025. In this article, we are going to take a look at where RLI Corp. (NYSE:RLI) stands against other mid-cap stocks insiders were buying in Q1 2025. Stock markets tumbled on Wednesday, with technology shares leading the slide amid growing concerns […]

Insider Monkey 1 hour ago

RLI

COMP
Alight, Inc. (ALIT): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

We recently published a list of 20 Mid-Cap Stocks Insiders Were Buying in Q1 2025. In this article, we are going to take a look at where Alight, Inc. (NYSE:ALIT) stands against other mid-cap stocks insiders were buying in Q1 2025. Stock markets tumbled on Wednesday, with technology shares leading the slide amid growing concerns […]

Insider Monkey 1 hour ago

COMP

ALIT
Arcosa, Inc. (ACA): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

We recently published a list of 20 Mid-Cap Stocks Insiders Were Buying in Q1 2025. In this article, we are going to take a look at where Arcosa, Inc. (NYSE:ACA) stands against other mid-cap stocks insiders were buying in Q1 2025. Stock markets tumbled on Wednesday, with technology shares leading the slide amid growing concerns […]

Insider Monkey 1 hour ago

ACA

COMP
JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics

JPMorgan analyst Hardik Parikh says Eli Lilly’s (LLY) Phase 3 data for orforglipron in type 2 diabetes suggest a “highly competitive profile” for the drug. The firm views the data as its base case scenario, whereby Structure Therapeutics (GPCR) shares could be up double-digit percent in this scenario on a “highly favorable read-through” and Viking Therapeutics (VKTX) could move mid-single-digit in either direction. JPMorgan’s focus was primarily on orfoglipron’s tolerability profile with the ext

TipRanks 1 hour ago

GPCR

LLY

VKTX

Performance Overview

Return	VIKRAMTH.BO	S&P BSE SENSEX (^BSESN)
YTD	-5.07%	+0.53%
1-Year	-3.33%	+7.69%
3-Year	-3.33%	+34.65%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Vikram Thermo (India) Limited (VIKRAMTH.BO)

Related News

This week in Trumponomics: War on the Fed

Berkshire Hathaway is top defensive pick, portfolio manager says

Netflix stock rises after earnings, outlook top Wall Street forecasts

How Eli Lilly's GLP-1 pill could transform the weight-loss space

Stocks close mixed as UnitedHealth drags on the Dow

UnitedHealth stock is crushing the Dow. Here's the math behind the slide.

Netflix Smashes Expectations with $10.54 Billion in Revenue

Trump Trade: President said to end IRS Direct File, block DeepSeek

H.C. Wainwright still expects Viking to ‘differentiate’ after Lilly data

Eli Lilly Vows to Make Weight-Loss Pill in U.S. as Trump Pushes for Domestic Manufacturing

Amkor Technology, Inc. (AMKR): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

Millrose Properties, Inc. (MRP): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

Eli Lilly jumps as results from weight-loss pill study rival competitor’s

Eli Lilly and BigHat Biosciences ink AI antibody discovery deal

Noble Corporation plc (NE): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

Eli Lilly and Company (LLY): One of the Best Long Term Stocks to Buy According to Billionaires

RLI Corp. (RLI): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

Alight, Inc. (ALIT): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

Arcosa, Inc. (ACA): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics

Performance Overview